Profile | GDS4284 / 233085_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1283.39 | 78 |
GSM687648 | Patient 402 control | 2019.04 | 84 |
GSM687653 | Patient 403 control | 1247.36 | 77 |
GSM687658 | Patient 404 control | 2656.52 | 87 |
GSM687663 | Patient 411 control | 2043.15 | 84 |
GSM687668 | Patient 422 control | 1504.44 | 80 |
GSM687673 | Patient 424 control | 1778.07 | 82 |
GSM687678 | Patient 425 control | 1893.89 | 83 |
GSM687683 | Patient 427 control | 1358.65 | 78 |
GSM687688 | Patient 428 control | 1467.79 | 80 |
GSM687695 | Patient 441 control | 3641.04 | 91 |
GSM687699 | Patient 443 control | 2870.85 | 88 |
GSM687704 | Patient 444 control | 1776.79 | 82 |
GSM687707 | Patient 448 control | 1471.21 | 80 |
GSM687712 | Patient 449 control | 3347.6 | 90 |
GSM687719 | Patient 450 control | 2614.69 | 87 |
GSM687724 | Patient 451 control | 1601.34 | 81 |
GSM687728 | Patient 452 control | 4872.41 | 93 |
GSM687646 | Patient 401 treated 24h | 1313.02 | 78 |
GSM687649 | Patient 402 treated 24h | 2223.37 | 85 |
GSM687665 | Patient 411 treated 24h | 2114.58 | 85 |
GSM687651 | Patient 402 treated 4 weeks | 1400.64 | 79 |
GSM687667 | Patient 411 treated 4 weeks | 2138.8 | 85 |
GSM687670 | Patient 422 treated 24h | 1820.61 | 82 |
GSM687671 | Patient 422 treated 4 weeks | 1447.06 | 79 |
GSM687654 | Patient 403 treated 24h | 1406.1 | 79 |
GSM687675 | Patient 424 treated 24h | 1959.5 | 84 |
GSM687685 | Patient 427 treated 24h | 1196.7 | 77 |
GSM687656 | Patient 403 treated 4 weeks | 1542.06 | 80 |
GSM687677 | Patient 424 treated 4 weeks | 1472.06 | 79 |
GSM687687 | Patient 427 treated 4 weeks | 1077.14 | 75 |
GSM687692 | Patient 428 treated 4h | 1738.86 | 82 |
GSM687716 | Patient 449 treated 4h | 2789.34 | 88 |
GSM687722 | Patient 450 treated 4h | 2976.73 | 89 |
GSM687680 | Patient 425 treated 24h | 2032.11 | 84 |
GSM687690 | Patient 428 treated 24h | 2644.61 | 87 |
GSM687700 | Patient 443 treated 24h | 3540.5 | 91 |
GSM687705 | Patient 444 treated 24h | 2716.37 | 88 |
GSM687714 | Patient 449 treated 24h | 3412.41 | 90 |
GSM687721 | Patient 450 treated 24h | 3339.99 | 90 |
GSM687682 | Patient 425 treated 4 weeks | 2240.08 | 85 |
GSM687694 | Patient 428 treated 4 weeks | 1738.63 | 81 |
GSM687702 | Patient 443 treated 4 weeks | 2799.07 | 88 |
GSM687718 | Patient 449 treated 4 weeks | 2900.79 | 88 |
GSM687723 | Patient 450 treated 4 weeks | 2017.2 | 84 |
GSM687661 | Patient 404 treated 4h | 2888.64 | 88 |
GSM687710 | Patient 448 treated 4h | 1446.54 | 80 |
GSM687726 | Patient 451 treated 4h | 1191.78 | 77 |
GSM687730 | Patient 452 treated 4h | 3653.44 | 92 |
GSM687660 | Patient 404 treated 24h | 14392.6 | 98 |
GSM687697 | Patient 441 treated 24h | 3600.81 | 91 |
GSM687709 | Patient 448 treated 24h | 1862.6 | 83 |
GSM687725 | Patient 451 treated 24h | 2422.84 | 87 |
GSM687729 | Patient 452 treated 24h | 8114.42 | 96 |
GSM687727 | Patient 451 treated 4 weeks | 832.947 | 71 |
GSM687731 | Patient 452 treated 4 weeks | 3153.54 | 89 |